wherein R1 and R2 are the same or different and are -CH=CH2, -CH/OH/CH3 and -CH/OR3/CH3, wherein R3 is group forming oligomer containing ether or ester bonds having from 1 to 5 identical or different units, either R1 and R2 are CHR4CH3; A is main amino acid; m= 2-4 and n=1-5. Compounds I are useful as agent for detecting and treating malignant tumors. EFFECT: improved properties of the pharmaceutical composition. 13 cl, 6 dwg, 26 ex, 4 tbl"/>
COMPLEX SALT OF HEMATOPORPHYRINE AND DERIVATIVES THEREOF, MIXTURE OF COMPLEX SALTS OF HEMATOPORHYRINE AND DERIVATIVES THEREOF, METHOD OF PREPARING COMPLEX SALTS, METHOD OF PREPARING MIXTURE OF COMPLEX SALTS, AND PHARMACEUTICAL COMPOSITION
首页>
外国专利>
COMPLEX SALT OF HEMATOPORPHYRINE AND DERIVATIVES THEREOF, MIXTURE OF COMPLEX SALTS OF HEMATOPORHYRINE AND DERIVATIVES THEREOF, METHOD OF PREPARING COMPLEX SALTS, METHOD OF PREPARING MIXTURE OF COMPLEX SALTS, AND PHARMACEUTICAL COMPOSITION
COMPLEX SALT OF HEMATOPORPHYRINE AND DERIVATIVES THEREOF, MIXTURE OF COMPLEX SALTS OF HEMATOPORHYRINE AND DERIVATIVES THEREOF, METHOD OF PREPARING COMPLEX SALTS, METHOD OF PREPARING MIXTURE OF COMPLEX SALTS, AND PHARMACEUTICAL COMPOSITION
FIELD: chemical industry. SUBSTANCE: complex salts of hematoporthyrine and derivatives thereof of formula 1: wherein R1 and R2 are the same or different and are -CH=CH2, -CH/OH/CH3 and -CH/OR3/CH3, wherein R3 is group forming oligomer containing ether or ester bonds having from 1 to 5 identical or different units, either R1 and R2 are CHR4CH3; A is main amino acid; m= 2-4 and n=1-5. Compounds I are useful as agent for detecting and treating malignant tumors. EFFECT: improved properties of the pharmaceutical composition. 13 cl, 6 dwg, 26 ex, 4 tbl
展开▼
